Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Coleman

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variantsIsis So, Jolina Lombardi, Adam M Staffaroni, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variantsIsis So, Jolina Lombardi, Adam M Staffaroni, et al.
Pageof 2